-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Oric Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q2 2025.
- Oric Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$36.4M, a 13.7% decline year-over-year.
- Oric Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$137M, a 23.9% decline year-over-year.
- Oric Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$128M, a 27% decline from 2023.
- Oric Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$101M, a 13% decline from 2022.
- Oric Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$89.1M, a 13.2% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)